Chronic myelogenous leukemia--update and future directions.
Kantarjian
H M
HM
Deisseroth
A
A
Talpaz
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D009857:Oncogenes; D011379:Prognosis; D012307:Risk Factors
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D016898:Interferon-alpha